Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 1/20 | 0.42 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.42 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | PRCP | P42785 | 2/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.37 |
| ▸ | KDM1A | O60341 | 2/20 | 0.36 |
| ▸ | CDYL2 | Q8N8U2 | 1/20 | 0.35 |
| ▸ | CDYL | Q9Y232 | 1/20 | 0.35 |
| ▸ | REN | P00797 | 1/20 | 0.35 |
| ▸ | CTSC | P53634 | 1/20 | 0.35 |
| ▸ | GHSR | Q92847 | 1/20 | 0.35 |
| ▸ | FURIN | P09958 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29680012 | 0.94 | MAPK8 (0.48) | MAPK8MAPK9MAPK10KEAP1PRCP | |
| SCHEMBL31720924 | 0.93 | PRCP (0.41) | MAPK8MAPK9MAPK10KEAP1PRCP | |
| SCHEMBL29531541 | 0.93 | PRCP (0.41) | MAPK8MAPK9MAPK10KEAP1PRCP | |
| SCHEMBL30686009 | 0.93 | MAPK8 (0.49) | MAPK8MAPK9MAPK10KEAP1PRCP | |
| SCHEMBL30686003 | 0.92 | MAPK8 (0.48) | MAPK8MAPK9MAPK10KEAP1PRCP | |
| SCHEMBL30686004 | 0.92 | MAPK8 (0.48) | MAPK8MAPK9MAPK10KEAP1PRCP | |
| SCHEMBL29531747 | 0.91 | KEAP1 (0.45) | MAPK8MAPK9MAPK10KEAP1PRCP | |
| SCHEMBL29531712 | 0.89 | PRCP (0.42) | MAPK8MAPK9MAPK10KEAP1PRCP | |
| SCHEMBL30974540 | 0.89 | NPY4R (0.51) | MAPK8MAPK9MAPK10KEAP1KDM1A | |
| SCHEMBL31019315 | 0.88 | PRCP (0.41) | MAPK8MAPK9MAPK10KEAP1PRCP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4547686-A1 | COMPOUND-DIAGNOSTIC MARKER FOR UTERINE BODY CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR DIAGNOSIS OF UTERINE BODY CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF UTERINE BODY CANCER | Urteste S.A. (PL) | 2025-05-07 | — | — | EP | claimed |
| WO-2024005658-A1 | COMPOUND-DIAGNOSTIC MARKER FOR UTERINE BODY CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR DIAGNOSIS OF UTERINE BODY CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF UTERINE BODY CANCER | URTESTE S.A. (PL) | 2024-01-04 | — | — | WO | claimed |
| US-20250376711-A1 | COMPOUND-DIAGNOSTIC MARKER FOR UTERINE BODY CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR DIAGNOSIS OF UTERINE BODY CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF UTERINE BODY CANCER | URTESTE S.A. (PL) | 2025-12-11 | — | — | US | disclosed |
| EP-4547686-A1 | COMPOUND-DIAGNOSTIC MARKER FOR UTERINE BODY CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR DIAGNOSIS OF UTERINE BODY CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF UTERINE BODY CANCER | Urteste S.A. (PL) | 2025-05-07 | — | — | EP | disclosed |
| CN-119451973-A | Compound-diagnostic marker for endometrial cancer, method for detecting enzymatic activity, method for diagnosing endometrial cancer, kit containing same, use of same and method for treating endometrial cancer | 尔特斯特公司 | 2025-02-14 | — | — | CN | disclosed |
| WO-2024005658-A1 | COMPOUND-DIAGNOSTIC MARKER FOR UTERINE BODY CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR DIAGNOSIS OF UTERINE BODY CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF UTERINE BODY CANCER | URTESTE S.A. (PL) | 2024-01-04 | — | — | WO | disclosed |